Dr Rino Coladangelo and Joe Smith have joined the international leadership team at Sage Healthcare, bringing experience in medicine, pharmaceutical businesses and corporate investment.
Rino, who is based in the UK, has worked across clinical medicine, NHS management, pharmaceutical services and corporate finance.
His career includes serving as managing director of clinical services at North Hertfordshire NHS Trust and co-founding healthcare market research business Medix UK.
He subsequently became chief executive of Rephine, a pharmaceutical quality and regulatory consultancy that he developed and led through its sale to private equity in 2021.
Rino is also managing director of Toro Corporate Finance, which advises on funding for pharmaceutical and life sciences projects. He trained in medicine at the University of London and holds MB BS and MRCP qualifications.
Joining him as a director is US-based Joe Smith, who has more than 20 years’ experience in the life sciences sector.
Joe has held senior corporate and business development roles at pharmaceutical and biotechnology companies including Impel, OncoSec, EyePoint and Valeant.
He founded BioVerity Partners in 2023 to support developing pharmaceutical businesses with strategic and commercial leadership. His earlier career includes consulting and capital markets experience with Navigant, Lazard and Bear Stearns.
Both men have been appointed directors at Sage Healthcare, an international advisory business supporting biotechnology, pharmaceutical and healthcare companies.
Dr William Mason, a director at Sage Healthcare, welcomed the appointments, highlighting the complementary experience Rino and Joe bring from their respective careers.
The two will work with colleagues across the company’s international operations, supporting businesses involved in pharmaceutical partnerships, acquisitions and investment.
